Andrew T. Parsa
Corresponding Author: Andrew T. Parsa
MD, PhD, Department of Neurological Surgery
University of California at San Francisco
Name/email consistency: high
- Supratentorial hemangioblastoma: clinical features, prognosis, and predictive value of location for von Hippel-Lindau disease. Mills, S.A., Oh, M.C., Rutkowski, M.J., Sughrue, M.E., Barani, I.J., Parsa, A.T. Neuro-oncology (2012)
- Soluble factors secreted by glioblastoma cell lines facilitate recruitment, survival, and expansion of regulatory T cells: implications for immunotherapy. Crane, C.A., Ahn, B.J., Han, S.J., Parsa, A.T. Neuro-oncology (2012)
- Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma. Parsa, A.T., Waldron, J.S., Panner, A., Crane, C.A., Parney, I.F., Barry, J.J., Cachola, K.E., Murray, J.C., Tihan, T., Jensen, M.C., Mischel, P.S., Stokoe, D., Pieper, R.O. Nat. Med. (2007)
- Prognostic significance of intracranial dissemination of glioblastoma multiforme in adults. Parsa, A.T., Wachhorst, S., Lamborn, K.R., Prados, M.D., McDermott, M.W., Berger, M.S., Chang, S.M. J. Neurosurg. (2005)
- Spinal cord and intradural-extraparenchymal spinal tumors: current best care practices and strategies. Parsa, A.T., Lee, J., Parney, I.F., Weinstein, P., McCormick, P.C., Ames, C. J. Neurooncol. (2004)
- Autologous adjuvant linked fibroblasts induce anti-glioma immunity: implications for development of a glioma vaccine. Parsa, A.T., Miller, J.I., Eggers, A.E., Ogden, A.T., Anderson, R.C., Bruce, J.N. J. Neurooncol. (2003)
